Precigen, Inc. EPS (Basic, from Discontinued Ops)

EPS (Basic, from Discontinued Ops) of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, from Discontinued Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, from Discontinued Ops) for the quarter ending December 31, 2021 was -0.0 (a -233.33% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, from Discontinued Ops) decreased by -102.0%
  • Annual EPS (Basic, from Discontinued Ops) for 2021 was 0.02 (a -105.0% decrease from previous year)
  • Annual EPS (Basic, from Discontinued Ops) for 2020 was -0.4 (a -60.0% decrease from previous year)
  • Annual EPS (Basic, from Discontinued Ops) for 2019 was -1.0 (a -2.91% decrease from previous year)
  • Twelve month EPS (Basic, from Discontinued Ops) ending December 31, 2021 was 0.02 (a 92.31% increase compared to previous quarter)
  • Twelve month trailing EPS (Basic, from Discontinued Ops) decreased by -112.5% year-over-year
Trailing EPS (Basic, from Discontinued Ops) for the last four month:
31 Dec '21 30 Sep '21 30 Jun '21 31 Mar '21
0.02 0.01 0.0 -0.16
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, from Discontinued Ops) of Precigen, Inc.

Most recent EPS (Basic, from Discontinued Ops)of PGEN including historical data for past 10 years.

Interactive Chart of EPS (Basic, from Discontinued Ops) of Precigen, Inc.

Precigen, Inc. EPS (Basic, from Discontinued Ops) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -0.0 0.0 0.0 0.02 0.02
2020 -0.01 -0.01 -0.16 -0.22 -0.4
2019 -0.87 -0.03 -0.04 -0.06 -1.0
2018 -1.03
2017 -0.39

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology